# US 2013/0280206 A1 · Stabilized polymeric thiol reagents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0280206 A1
- Document ID: US20130280206A1
- Status: Published application
- Kind: A1
- Application number: 13/921,889
- Filed: 2013-06-19
- Published: 2013-10-24
- Earliest claimed: 2004-12-21
- Assignees: Nektar Therapeutics
- Applicants: Nektar Therapeutics
- Inventors: Antoni Kozlowski; Samuel P. Mcmanus
- Web page: https://patentgrep.com/patent/US20130280206A1

## CPC

- C07D 213/71: to which a second hetero atom is attached
- A61K 31/415: 1,2-Diazoles
- A61K 47/60: the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
- C07C 323/12: the carbon skeleton being acyclic and saturated
- C07D 213/70: Sulfur atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

Disclosed are water soluble polymeric conjugates comprising the structure POLY-[Y—S—S-A]x, where POLY is a water soluble polymer; Y is a hydrocarbon-based spacer group, x is 1 to 2, S—S is a disulfide group attached to an sp3 hybridized carbon of Y; and A is a covalently linked residue of a pharmacologically active molecule. Preferably, the water soluble polymer is a PEG polymer. Also disclosed are polymeric reagents useful to prepare such conjugates, and methods of their formation and use.

## Claims

### Claim 1

A polymer conjugate comprising the structure:
POLY-[Y—S—S-A]x
wherein:
POLY is a water soluble polymer which is a polyethylene glycol;
Y is a divalent linking group consisting of a saturated hydrocarbon backbone which is 4 to 6 carbon atoms in length and has substitutents selected from the hydrogen and methyl;
S—S is a disulfide group attached to an sp3 hybridized carbon of Y; and
A is a covalently linked residue of a pharmacologically active molecule; and
x is 1 or 2.

### Claim 2 (depends on 1)

The conjugate of claim 1, wherein said conjugate is water soluble.

### Claim 3 (depends on 1)

The conjugate of claim 1, wherein each of R1 and R2 is hydrogen.

### Claim 4 (depends on 1)

The conjugate of claim 1, wherein said pharmacologically active molecule has a reactive thiol group in its unconjugated form and is selected from the group consisting of proteins, peptides, and small molecules.

### Claim 5 (depends on 1)

The conjugate of claim 1, comprising the structure A-S—S—Y-POLY-Y—S—S-A.

### Claim 6 (depends on 5)

The conjugate of claim 5, wherein the Y groups are identical.

### Claim 7 (depends on 1)

The conjugate of claim 1, in combination with a pharmaceutical excipient.

### Claim 8 (depends on 7)

The conjugate of claim 7, wherein said pharmaceutical excipient is an aqueus carrier.

### Claim 9 (depends on 1)

The conjugate of claim 1, wherein x is 1.

### Claim 10 (depends on 1)

The conjugate of claim 1, wherein x is 2.

### Claim 11

A composition comprising, in a pharmaceutically acceptable carrier, a conjugate having the structure:
POLY-[Y—S—S-A]x
wherein:
POLY is a water soluble polymer which is a polyethylene glycol;
Y is a divalent linking group consisting of a saturated hydrocarbon backbone which is 4 to 6 carbon atoms in length and has substitutents selected from the hydrogen and methyl;
S—S is a disulfide group attached to an sp3 hybridized carbon of Y; and
A is a covalently linked residue of a pharmacologically active molecule, wherein said pharmacologically active molecule has a reactive thiol group in unconjugated form; and
x is 1 or 2.
